This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Immunocore Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Marine Raman: Innovator in T Cell Receptor Technology
Introduction
Marine Raman is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunotherapy, particularly through his work on T cell receptors. His innovative approach aims to enhance the treatment of malignant diseases.
Latest Patents
Marine Raman holds a patent related to T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide GVYDGREHTV. This invention focuses on TCRs derived from the germline cancer antigen MAGE A4. The TCRs may include non-natural mutations within the alpha and/or beta variable domains compared to a native MAGE A4 TCR. These TCRs are particularly suitable for use as novel immunotherapeutic reagents for treating malignant diseases. He has 1 patent to his name.
Career Highlights
Marine Raman is associated with Immunocore Limited, a company that specializes in developing innovative therapies for cancer treatment. His work has positioned him as a key figure in the advancement of immunotherapeutic strategies.
Collaborations
Marine collaborates with talented individuals such as Conor Hayes and Linda Hibbert, who contribute to the innovative environment at Immunocore Limited.
Conclusion
Marine Raman's contributions to T cell receptor technology represent a significant advancement in the field of immunotherapy. His work continues to pave the way for new treatment options for patients with malignant diseases.